Characteristics of clinical trials for haematological malignancies from 2015 to 2020: A systematic review
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference36 articles.
1. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century;Pulte;Blood Cancer J,2020
2. A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017;Keykhaei;Exp Hematol Oncol,2021
3. Annual report to the nation on the status of cancer, Part 1: national cancer statistics;Islami,2021
4. Level of evidence for FDA drug approvals in pivotal clinical trials of hematological malignancies;Al Hadidi;Leuk Lymphoma,2021
5. Why is research in early-stage cancer research so low?;Prasad;J Cancer Policy,2018
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiac Toxicity in the Treatment of Light Chain Amyloidosis: Systematic Review of Clinical Studies;Current Drug Safety;2024-11
2. [Translated article] Characteristics, clinical benefit, and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020;Farmacia Hospitalaria;2024-07
3. Características, beneficio clínico y financiación de las nuevas autorizaciones de fármacos oncohematológicos en España entre 2017 y 2020;Farmacia Hospitalaria;2024-05
4. Point de vue sur la qualité de vie;Hématologie;2024-03-01
5. Molecular Mechanisms of Immune Checkpoints as an Immunotherapy Tool in Hematological Malignancies;Reference Module in Biomedical Sciences;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3